Clinical Services > Infection Control

Partnership delivers smart, reusable PPE solutions

15 February, 2021

RFiD Discovery and Welspring have partnered to offer high-quality, reusable and trackable protective garments for frontline healthcare workers.


Long-lasting infection-control solution now available in Australia

12 February, 2021

SurfaceWise2, a hospital-grade disinfectant that makes surfaces hostile to germs for up to three months, has been launched in Australia by Allied BioServices.


Russian Sputnik vaccine demonstrates 91.6% efficacy

08 February, 2021

Preliminary results from the Russian COVID-19 phase 3 vaccine trial suggest that the two-dose vaccine regimen is 91.6% efficacious against symptomatic COVID-19.


Aus biotech company supplies at-home COVID-19 tests to US

05 February, 2021 by Lauren Davis

Queensland-based company Ellume has announced a US$231.8 million (AU$302.7 million) agreement to accelerate domestic US production of its COVID-19 home tests.


Novavax vaccine demonstrates 89.3% efficacy

03 February, 2021

Novavax has announced that its protein-based COVID-19 vaccine candidate has demonstrated a vaccine efficacy of 89.3% in a Phase 3 clinical trial conducted in the UK.


Monash innovation reduces risk of COVID in healthcare workers

29 January, 2021

A Monash University study reveals that a simple ventilated headboard hood can stop SARS-CoV-2 from spreading between patients and healthcare workers on hospital wards.


TGA approves Pfizer/BioNTech vaccine

25 January, 2021

The Australian Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer/BioNTech COVID-19 mRNA vaccine, COMIRNATY.


Getting to know your disinfectants

21 January, 2021

For general and high-risk environments


GPs to take lead role in COVID-19 vaccine rollout

14 January, 2021

The RACGP has welcomed government confirmation that GPs will be at the forefront of Australia's COVID-19 vaccine rollout.


Monash researchers outsmart superbug

13 January, 2021

Researchers have discovered how to revert antibiotic resistance in one of the most dangerous superbugs: Acinetobacter baumannii — responsible for up to 20% of infections in ICUs.


Experts comment on early COVID vaccination rollout

08 January, 2021

Australia's coronavirus vaccine rollout will be brought forward to next month, with Prime Minister Scott Morrison saying the first groups are expected to receive the jab in mid-to-late February.


Con-Serv Antimicrobial range

01 January, 2021

Con-Serv has partnered with Biomaster to introduce a range of antimicrobial products, including showerheads, shower hoses, sliders and aerators.


Candida auris — a fungus with attitude

01 January, 2021

Multidrug-resistant C. auris is an important emerging pathogen which demands attention and action when identified in the healthcare setting.


Vehicle partition screens: the PPE for healthcare rides

22 December, 2020 by Megan Whelan*

Recent months have seen growing demand for partition screens in many countries to ensure extra precaution and mitigate the risks of coronavirus infection among drivers.


Isolation on demand, wherever you need it

17 December, 2020

Clinell Rediroom is an innovative alternative to increase the availability of additional isolation space to help prevent infections and save lives.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd